International Medicine and Health Guidance News ›› 2022, Vol. 28 ›› Issue (3): 315-320.DOI: 10.3760/cma.j.issn.1007-1245.2022.03.005
• Scientific Research • Previous Articles Next Articles
Weng Yijie, Li Liangsheng, Zhong Xiangxin, Deng Feifu, Wang Yichang, Wei Jinsong
Received:
2021-11-02
Online:
2022-02-01
Published:
2022-03-01
Contact:
Wei Jinsong, Email: jlgdwei@163.com
Supported by:
Natural Science Foundation of Guangdong Province in 2021 (2021A1515010975)
翁一杰 黎良盛 钟向新 邓妃富 王义昌 魏劲松
通讯作者:
魏劲松,Email:jlgdwei@163.com
基金资助:
Weng Yijie, Li Liangsheng, Zhong Xiangxin, Deng Feifu, Wang Yichang, Wei Jinsong. Diagnosis and treatment of osteoporosis and current status of treatment with mesenchymal stem cells[J]. International Medicine and Health Guidance News, 2022, 28(3): 315-320.
翁一杰, 黎良盛, 钟向新, 邓妃富, 王义昌, 魏劲松. 骨质疏松症的诊治及应用间充质干细胞的治疗现状[J]. 国际医药卫生导报, 2022, 28(3): 315-320.
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.imhgn.com/EN/10.3760/cma.j.issn.1007-1245.2022.03.005
[1] Conference CD.Diagnosis, prophylaxis, and treatment of osteoporosis[J]. Am J Med, 1993,94(6):646-650. DOI: 10.1016/0002-9343(93)90218-e. [2] Singh SV, Tripathi A. An overview of osteoporosis for the practising prosthodontist[J]. Gerodontology, 2010,27(4):308-314. DOI: 10.1111/j.1741-2358.2009.00324.x. [3] Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report[J]. Osteoporos Int, 1994,4(6):368-381. DOI: 10.1007/BF01622200. [4] Eriksen EF. Treatment of osteopenia[J]. Rev Endocr Metab Disord, 2012,13(3):209-223. DOI: 10.1007/s11154-011-9187-z. [5] Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis[J]. Osteoporos Int, 2007,18(4):427-444. DOI: 10.1007/s00198-006-0253-4. [6] Dawson-Hughes B, Tosteson AN, Melton LJ, et al. Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA[J]. Osteoporos Int, 2008,19(4):449-458. DOI: 10.1007/s00198-008-0559-5. [7] Martin TJ, Seeman E. Bone remodelling: its local regulation and the emergence of bone fragility[J]. Best Pract Res Clin Endocrinol Metab, 2008,22(5):701-722. DOI: 10.1016/j.beem.2008.07.006. [8] Hadjidakis DJ, Androulakis II. Bone remodeling[J]. Ann N Y Acad Sci, 2006,1092:385-396. DOI: 10.1196/annals.1365.035.. [9] Kim BJ, Koh JM. Coupling factors involved in preserving bone balance[J]. Cell Mol Life Sci, 2019,76(7):1243-1253. DOI: 10.1007/s00018-018-2981-y. [10] Zuo C, Huang Y, Bajis R, et al. Osteoblastogenesis regulation signals in bone remodeling[J]. Osteoporos Int, 2012,23(6):1653-1663. DOI: 10.1007/s00198-012- 1909-x. [11] Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells[J]. Cell Tissue Kinet, 1970,3(4):393-403. DOI: 10.1111/j.1365-2184. 1970.tb00347.x. [12] Kassem M, Abdallah BM, Saeed H. Osteoblastic cells: differentiation and trans-differentiation[J]. Arch Biochem Biophys, 2008,473(2):183-187. DOI: 10.1016/j.abb. 2008.03.028. [13] Dezawa M, Ishikawa H, Itokazu Y, et al. Bone marrow stromal cells generate muscle cells and repair muscle degeneration[J]. Science, 2005,309(5732):314-317. DOI: 10.1126/science.1110364. [14] Rodrigo SF, van Ramshorst J, Hoogslag GE, et al. Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-up[J]. J Cardiovasc Transl Res, 2013,6(5):816-825. DOI: 10.1007/s12265-013- 9507-7. [15] Ariffin SH, Manogaran T, Abidin IZ, et al. A Perspective on stem cells as biological systems that produce differentiated osteoblasts and odontoblasts[J]. Curr Stem Cell Res Ther, 2017,12(3):247-259. DOI: 10.2174/1574888X11666161026145149. [16] Wang Q, Zhao B, Li C, et al. Decreased proliferation ability and differentiation potential of mesenchymal stem cells of osteoporosis rat[J]. Asian Pac J Trop Med, 2014,7(5):358-363. DOI: 10.1016/S1995-7645(14)60055-9. [17] Hu L, Yin C, Zhao F, et al. Mesenchymal stem cells: cell fate decision to osteoblast or adipocyte and application in osteoporosis treatment[J]. Int J Mol Sci, 2018,19(2):360. DOI: 10.3390/ijms19020360. [18] Tokuzawa Y, Yagi K, Yamashita Y, et al. Id4, a new candidate gene for senile osteoporosis, acts as a molecular switch promoting osteoblast differentiation[J]. PLoS Genet, 2010,6(7):e1001019. DOI: 10.1371/journal.pgen.1001019. [19] Dawson-Hughes B, Harris SS, Krall EA, et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older[J]. N Engl J Med, 1997,337(10):670-676. DOI: 10.1056/NEJM199709043371003. [20] Baccaro LF, Conde DM, Costa-Paiva L, et al. The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil[J]. Clin Interv Aging, 2015,10:583-591. DOI: 10.2147/CIA.S54614. [21] 陈镜,冯正平.骨质疏松症治疗药物研究进展[J].中国骨质疏松杂志,2021,27(5):776-780.DOI:10.3969/j.issn.1006-7108.2021.05.029. [22] Phetfong J, Sanvoranart T, Nartprayut K, et al. Osteoporosis: the current status of mesenchymal stem cell-based therapy[J]. Cell Mol Biol Lett, 2016,21:12. DOI: 10.1186/s11658-016-0013-1. [23] Shi Z, Zhou H, Pan B, et al. Effectiveness of teriparatide on fracture healing: a systematic review and meta-analysis[J]. PLoS One, 2016,11(12):e0168691. DOI: 10.1371/journal.pone.0168691. [24] Lombardi G, Di Somma C, Rubino M, et al. The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics[J]. J Endocrinol Invest, 2011,34(7 Suppl):18-22. [25] Corrado A, Sanpaolo ER, Di Bello S, et al. Osteoblast as a target of anti-osteoporotic treatment[J]. Postgrad Med, 2017,129(8):858-865. DOI: 10.1080/00325481.2017. 1362312. [26] Lindsay R, Krege JH, Marin F, et al. Teriparatide for osteoporosis: importance of the full course[J]. Osteoporos Int, 2016,27(8):2395-2410. DOI: 10.1007/s00198-016- 3534-6. [27] Canalis E, Giustina A, Bilezikian JP. Mechanisms of anabolic therapies for osteoporosis[J]. N Engl J Med, 2007,357(9):905-916. DOI: 10.1056/NEJMra067395. [28] Van Beek ER, Löwik CW, Papapoulos SE. Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors[J]. Bone, 2002,30(1):64-70. DOI: 10.1016/s8756-3282(01)00655-x. [29] Rodan GA, Reszka AA. Bisphosphonate mechanism of action[J]. Curr Mol Med, 2002,2(6):571-577. DOI: 10.2174/1566524023362104. [30] Rogers MJ, Crockett JC, Coxon FP,et al. Biochemical and molecular mechanisms of action of bisphosphonates[J]. Bone, 2011,49(1):34-41. DOI: 10.1016/j.bone.2010. 11.008. [31] Yarom N, Yahalom R, Shoshani Y, et al. Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome[J]. Osteoporos Int, 2007,18(10):1363-1370. DOI: 10.1007/s00198-007-0384-2. [32] Abrahamsen B, Eiken P, Eastell R. Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study[J]. J Bone Miner Res, 2009,24(6):1095-1102. DOI: 10.1359/jbmr.081247.. [33] Deal C. Potential new drug targets for osteoporosis[J]. Nat Clin Pract Rheumatol, 2009,5(1):20-27. DOI: 10.1038/ncprheum0977. [34] Martin A, Xiong J, Koromila T, et al. Estrogens antagonize RUNX2-mediated osteoblast-driven osteoclastogenesis through regulating RANKL membrane association[J]. Bone, 2015,75:96-104. DOI: 10.1016/j.bone.2015.02.007. [35] Rodríguez JP, Astudillo P, Ríos S, et al. Involvement of adipogenic potential of human bone marrow mesenchymal stem cells (MSCs) in osteoporosis[J]. Curr Stem Cell Res Ther, 2008,3(3):208-218. DOI: 10.2174/157488808785740325. [36] Kim RY, Yang HJ, Song YM, et al. Estrogen modulates bone morphogenetic protein-induced sclerostin expression through the wnt signaling pathway[J]. Tissue Eng Part A, 2015,21(13-14):2076-2088. DOI: 10.1089/ten.TEA.2014. 0585. [37] Post S, Abdallah BM, Bentzon JF, et al. Demonstration of the presence of independent pre-osteoblastic and pre-adipocytic cell populations in bone marrow-derived mesenchymal stem cells[J]. Bone, 2008,43(1):32-39. DOI: 10.1016/j.bone.2008.03.011. [38] Barrett-Connor E, Mosca L, Collins P, et al. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women[J]. N Engl J Med, 2006,355(2):125-137. DOI: 10.1056/NEJMoa062462. [39] Paspaliaris V, Kolios G. Stem cells in osteoporosis: from biology to new therapeutic approaches[J]. Stem Cells Int, 2019,2019:1730978. DOI: 10.1155/2019/1730978. [40] Marie PJ, Felsenberg D, Brandi ML. How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis[J]. Osteoporos Int, 2011,22(6):1659-1667. DOI: 10.1007/s00198-010-1369-0. [41] Reginster JY, Brandi ML, Cannata-Andía J, et al. The position of strontium ranelate in today's management of osteoporosis[J]. Osteoporos Int, 2015,26(6):1667-1671. DOI: 10.1007/s00198-015-3109-y. [42] 钟旭丽,封宇飞,张君莉.新型骨吸收抑制剂地诺单抗的药理与临床研究[J].中国新药杂志,2011,20(5):389-392. [43] Chen J, Smerdely P. Hypocalcaemia after denosumab in older people following fracture[J]. Osteoporos Int, 2017,28(2):517-522. DOI: 10.1007/s00198-016-3755-8. [44] Liu L, Webster TJ. In situ sensor advancements for osteoporosis prevention, diagnosis, and treatment[J]. Curr Osteoporos Rep, 2016,14(6):386-395. DOI: 10.1007/s11914-016-0339-7. [45] Kolios G. Animal models of inflammatory bowel disease: how useful are they really?[J]. Curr Opin Gastroenterol, 2016,32(4):251-257. DOI: 10.1097/MOG. 0000000000000287. [46] Ye X, Zhang P, Xue S, et al. Adipose-derived stem cells alleviate osteoporosis by enhancing osteogenesis and inhibiting adipogenesis in a rabbit model[J]. Cytotherapy, 2014,16(12):1643-1655. DOI: 10.1016/j.jcyt.2014. 07. 009. [47] Lien CY, Chih-Yuan Ho K, Lee OK, et al. Restoration of bone mass and strength in glucocorticoid-treated mice by systemic transplantation of CXCR4 and cbfa-1 co-expressing mesenchymal stem cells[J]. J Bone Miner Res, 2009,24(5):837-848. DOI: 10.1359/jbmr.081257. [48] Chen HT, Lee MJ, Chen CH, et al. Proliferation and differentiation potential of human adipose-derived mesenchymal stem cells isolated from elderly patients with osteoporotic fractures[J]. J Cell Mol Med, 2012,16(3):582-593. DOI: 10.1111/j.1582-4934.2011.01335.x. [49] Iaquinta MR, Mazzoni E, Bononi I, et al. Adult stem cells for bone regeneration and repair[J]. Front Cell Dev Biol, 2019,7:268. DOI: 10.3389/fcell.2019.00268. [50] Parikh SN. Gene therapy: principles and clinical applications in orthopedics[J]. Orthopedics, 2004,27(3):294-303; quiz 304-305. DOI: 10.3928/0147-7447- 20040301-14. [51] Centeno CJ, Busse D, Kisiday J, et al. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells[J]. Pain Physician, 2008,11(3):343-353. [52] Lee DS, Choung HW, Kim HJ, et al. NFI-C regulates osteoblast differentiation via control of osterix expression[J]. Stem Cells, 2014,32(9):2467-2479. DOI: 10.1002/stem.1733. [53] James AW. Review of signaling pathways governing MSC osteogenic and adipogenic differentiation[J]. Scientifica (Cairo), 2013,2013:684736. DOI: 10.1155/2013/684736. [54] Lin GL, Hankenson KD. Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation[J]. J Cell Biochem, 2011,112(12):3491-3501. DOI: 10.1002/jcb.23287. [55] Kim D, Cho SW, Her SJ, et al. Retrovirus-mediated gene transfer of receptor activator of nuclear factor-kappaB-Fc prevents bone loss in ovariectomized mice[J]. Stem Cells, 2006,24(7):1798-1805. DOI: 10.1634/stemcells. 2005-0480. [56] Sanchez-Fernandez MA, Gallois A, Riedl T, et al. Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor beta signaling[J]. PLoS One, 2008,3(10):e3537. DOI: 10.1371/journal.pone.0003537. [57] Lim RZL, Li L, Yong EL, et al. STAT-3 regulation of CXCR4 is necessary for the prenylflavonoid Icaritin to enhance mesenchymal stem cell proliferation, migration and osteogenic differentiation[J]. Biochim Biophys Acta Gen Subj, 2018,1862(7):1680-1692. DOI: 10.1016/j.bbagen. 2018.04.016. [58] Zhao YM, Li JY, Lan JP, et al. Cell cycle dependent telomere regulation by telomerase in human bone marrow mesenchymal stem cells[J]. Biochem Biophys Res Commun, 2008,369(4):1114-1119. DOI: 10.1016/j.bbrc. 2008.03.011. |
[1] | Wu Xueting, Chen Xiaoyi, Wu Yiwen, Cai Yongna, Xiao Mingyue, Chen Fengjuan, Han Qianglin, Qiu Shaodong, Zhu Zhiming, Chen Fei. Advances in the application of ultrasound radiomics in breast cancer [J]. International Medicine and Health Guidance News, 2022, 28(4): 484-487. |
[2] | Yu Wenlong, Yin Xiaowei, Yang Yuzhu, Xu Yanmei. One case of giant breast adenosquamous carcinoma and literature review [J]. International Medicine and Health Guidance News, 2022, 28(3): 419-421. |
[3] | Wang Xinyu, Ba Chenghui, Jiang Xingyue. Current situation and research progress of imaging diagnosis of acute intestinal ischemia [J]. International Medicine and Health Guidance News, 2022, 28(2): 196-199. |
[4] | Wang Xiaoping, Yan Xiaoqiang. Application value of ultrasonography in the diagnosis and clinical classification of appendicitis in children [J]. International Medicine and Health Guidance News, 2022, 28(2): 241-243. |
[5] | Liu Yue. Research progress and misdiagnosis of pyogenic granuloma [J]. International Medicine and Health Guidance News, 2022, 28(1): 140-144. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||